Fanny Monneaux
Strasbourg, 67084, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Targeting B and T Lymphocyte Attenuator Regulates Lupus Disease Development in NZB/W Mice.
Journal: ImmunoTargets and therapy
Published: August 30, 2024
Identification of new candidate drugs for primary Sjögren's syndrome using a drug repurposing transcriptomic approach.
Journal: Rheumatology (Oxford, England)
Published: October 03, 2022
High BTLA Expression Likely Contributes to Contraction of the Regulatory T Cell Subset in Lupus Disease.
Journal: Frontiers in immunology
Published: August 30, 2021
Defective BTLA functionality is rescued by restoring lipid metabolism in lupus CD4+ T cells.
Journal: JCI insight
Published: January 09, 2018
Follicular Helper T Cells in Systemic Lupus Erythematosus: Why Should They Be Considered as Interesting Therapeutic Targets?
Journal: Journal of immunology research
Published: May 04, 2016
Circulating TFH subset distribution is strongly affected in lupus patients with an active disease.
Journal: PloS one
Published: May 09, 2013
Novel glycolipid TLR2 ligands of the type Pam2Cys-α-Gal: synthesis and biological properties.
Journal: European journal of medicinal chemistry
Published: October 21, 2011
Showing 1-10 of 10
Last Updated: 09/26/2026